Startups
Rigenerand is a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology.
Our philosophy is the need to fill gaps in the generation of 3D diagnostics and cell manufacturing based on innovative devices that conjugate precision medicine, safety, low cost of manufacturing and a progressive automation.
Simultaneously, Rigenerand aims to fill therapeutics gaps for still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer.
The Company has two corporate units: Biodisposable and Therapeutics. All this is possible thanks to the experience in medical device research and manufacturing and by the advantages of fully equipped research laboratories together with 500 sqm of cGMP classified suites.
Our philosophy is the need to fill gaps in the generation of 3D diagnostics and cell manufacturing based on innovative devices that conjugate precision medicine, safety, low cost of manufacturing and a progressive automation.
Simultaneously, Rigenerand aims to fill therapeutics gaps for still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer.
The Company has two corporate units: Biodisposable and Therapeutics. All this is possible thanks to the experience in medical device research and manufacturing and by the advantages of fully equipped research laboratories together with 500 sqm of cGMP classified suites.
Overview
Location
Italy, Emilia-Romagna, Villafranca
Employees
11-50
Total raised
$9.94M
Founded date
2009
FAQ about Rigenerand srl
When was Rigenerand srl founded?
Rigenerand srl was founded in 2009.
How much funding has Rigenerand srl raised?
Rigenerand srl has raised $9.94M in total across 1 funding round.
Is Rigenerand srl still active?
Yes, Rigenerand srl is active; its latest activity on Parsers VC dates from May 11, 2016.